IndraLab

Statements


| 2

reach
"Together, the data demonstrate that, as a DUB of HIF1alpha, USP29 promotes Sorafenib resistance in HCC cells, in parts by upregulating glycolysis, thereby opening new avenues for therapeutically targeting Sorafenib-resistant HCC in patients."

reach
"USP29 promotes sorafenib resistance in vivo."